In research models, GHK-Cu has been shown to promote collagen and elastin synthesis , enhance fibroblast proliferation , and accelerate tissue regeneration
This matters especially for cancer patients, as GHK-Cu may even increase cancer progression risk
NIOD focuses on optimizing skin at multiple stages of life, operating within the biological realities of skin, for example its capacity to regenerate at night
To move Epitalon from experimental to evidence-based, several developments are essential: Randomized, double-blind, placebo-controlled clinical trials, ideally targeting specific endpoints (sleep, immune aging, telomere attrition) Toxicology and long-term safety studies, including exploration of stereoisomer effects and off-target consequences Validated delivery systems (e.g., dendrimer-conjugates, transdermal patches) that make real-world use feasible Pharmacodynamic biomarkers, to identify responders and track efficacy objectively over time Epitalon is not snake oil, but its also not a magic bullet